A machine learning tool incorporating both clinical and genomic data helps predict response to CDK4/6 inhibitor therapy in ...

The FDA has approved ensartinib in adult patients with anaplastic lymphoma kinase (ALK)–positive locally advanced or ...

The FDA approved ensartinib (Ensacove) as a first-line treatment for adults with ALK -positive locally advanced or metastatic ...

The Food and Drug Administration has approved Ensacove for patients with ALK-positive locally advanced or metastatic ...

Ensartinib has received FDA approval for the first-line treatment of ALK-positive locally advanced or metastatic non–small ...

New research published Wednesday in the journal Environmental Science and Technology offers evidence that microplastics are ...

Compared with originator bevacizumab, the biosimilar version of bevacizumab had equal efficacy when used to treat metastatic ...

We recently compiled a list of the 10 Chinese Penny Stocks to Buy According to Analysts. In this article, we are going to ...

San Antonio Breast Cancer Symposium was held from Dec. 10 to 13 in San Antonio. Attendees included medical oncologists, ...

For many people with early breast cancer (eBC), remission doesn’t mean everything goes back to normal. There are scars from ...

Nurses play an important role in the administration of biosimilars and the education of patients receiving them.

A promising breakthrough in the fight against cancer emerges from Russia. The cancer vaccine developed by the Gamaleya Center ...